A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s DiseaseSatish Keshav, Tomáš Vaňásek, Yaron Niv et al.|PLoS ONE|2013Cited by 134
A randomized placebo-controlled trial of pegylated interferon alpha in active ulcerative colitisHerbert Tilg, Walter Reinisch, Harald Vogelsang et al.|Gastroenterology|2003Cited by 91
Competition for Clinical Trials in Inflammatory Bowel DiseasesM. Scott Harris, Walter Reinisch, Jolanta Wichary et al.|Gastroenterology|2019Cited by 71
Placebo Response Rate in Clinical Trials of Fistulizing Crohn's Disease: Systematic Review and Meta-analysisAlexander C. Ford, Walter Reinisch, Simon Travis et al.|Clinical Gastroenterology and Hepatology|2014Cited by 23